Reinforcement device
Description
Claims
The ornamental design for the reinforcement device as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D493223 | July 20, 2004 | Solymar |
D713527 | September 16, 2014 | Heipl |
D727500 | April 21, 2015 | Heipl |
D727501 | April 21, 2015 | Heipl |
D728102 | April 28, 2015 | Heipl |
9687245 | June 27, 2017 | Molaei |
D1014758 | February 13, 2024 | Lima |
11903588 | February 20, 2024 | Yang |
11931041 | March 19, 2024 | Hamel |
12053182 | August 6, 2024 | Aboytes |
20130116722 | May 9, 2013 | Aboytes |
20170224355 | August 10, 2017 | Bowman |
20170367713 | December 28, 2017 | Greene, Jr. |
20200187954 | June 18, 2020 | Hamel |
20220022882 | January 27, 2022 | Aboytes |
20230190292 | June 22, 2023 | Choubey |
20240050096 | February 15, 2024 | Warner |
20240090903 | March 21, 2024 | Connor |
20240122600 | April 18, 2024 | Oslund |
001940610-0002 | November 2011 | EM |
001940610-0005 | November 2011 | EM |
D1458543 | December 2012 | JP |
2017099978 | June 2017 | JP |
- Neuro News International, Medina embolisation device represents “a major step forward” in aneurysm treatment, Published on Dec. 21, 2016, Journal of NeuroInterventional Surgery, Retrieved from Internet: https://neuronewsinternational.com/medina-embolisation-device-represents-a-major-step-forward-in-aneurysm-treatment/ (Year: 2016).
- Adam A. Dmytriw, MD,MSc, Endosaccular Flow Disruption: A New Frontier in Endovascular Aneurysm Management, Published on: Mar. 5, 2019, neurosurgery-online.com, Retrieved from Internet: https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7239377&blobtype=pdf (Year: 2019).
- P. Bhogal , The ContourEarly Human Experience of a Novel Aneurysm Occlusion Device, Published on: Jan. 28, 2020, Springer-Verlag GmbH, Retrieved from Internet: https://www.researchgate.net/publication/338886949_The_Contour-Early_Human_Experience_of_a_Novel_Aneurysm_Occlusion_Device (Year: 2020).
Patent History
Patent number: D1057957
Type: Grant
Filed: Jul 21, 2021
Date of Patent: Jan 14, 2025
Inventor: Maria G. Aboytes (Palo Alto, CA)
Primary Examiner: Jennifer L Rempfer
Assistant Examiner: Edward P Jones
Application Number: 29/800,544
Type: Grant
Filed: Jul 21, 2021
Date of Patent: Jan 14, 2025
Inventor: Maria G. Aboytes (Palo Alto, CA)
Primary Examiner: Jennifer L Rempfer
Assistant Examiner: Edward P Jones
Application Number: 29/800,544
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)